Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Green, MMB; Horwitz, ME; Kang, Y; Chao, NJ; Long, GD; Rizzieri, D; Gasparetto, C; Sung, AD; Sarantopoulos, S; Li, Z; Corbet, K; Riggan-Stuelke, E; Sullivan, K; Wilson, B; Chhabra, S; Costa, LV; Mims, A; Stuart, R

Published Date

  • February 2015

Published In

Volume / Issue

  • 21 / 2

Start / End Page

  • S31 - S32

Published By

International Standard Serial Number (ISSN)

  • 1083-8791

Digital Object Identifier (DOI)

  • 10.1016/j.bbmt.2014.11.024